Skip to main content
. 2020 Oct 30;31(1):144–153. doi: 10.4014/jmb.2006.06044

Table 3.

Catalytic rates of GV-hybrids.

Substrate Clone Mutational composition kcat(min-1) Km(μM) kcat/Km
(×106M-1min-1)
Fold increase to G0 Fold increase to V0 Fold increase to GV0

Paraoxon G0 (rePON1-4E9) 9.1 ± 0.01 29.4 ± 0.6 0.3 ± 0.01 1.0 - -
V0 (OPH-11M) 705.3 ± 16.59 220.4 ± 1.1 3.2 ± 0.06 10.4 1.0 -
GV0 G0-V0 hybrid 146.1 ± 8.26 27.7 ± 4.7 5.3 ± 0.59 17.2 1.7 1.0
GV1 G0-V1 hybrid 3024.7 ± 99.40 214.4 ± 9.0 14.1 ± 0.13 45.7 4.4 2.7
GV2 G9-V2 hybrid 3271.3 ± 47.17 247.9 ± 4.7 13.2 ± 0.06 42.7 4.1 2.5
GV3 G9-V3 hybrid 2366.3 ± 35.38 219.3 ± 6.7 10.8 ± 0.49 35.0 3.4 2.0
GV4 G10-V2 hybrid 3061.6 ± 29.20 184.9 ± 12.5 16.6 ± 0.96 53.7 5.2 3.1
GV5 G10-V3 hybrid 1541.1 ± 25.27 105.3 ± 4.7 14.7 ± 0.42 47.5 4.6 2.8
GV6 G11-V2 hybrid 1676.6 ± 59.53 105.3 ± 13.0 16.0 ± 1.41 51.8 5.0 3.0
GV7 G11-V3 hybrid 3258.6 ± 51.67 54.5 ± 0.9 59.8 ± 0.06 193.7 18.7 11.3
PNPDPP G0 (rePON1-4E9) 4.0 ± 0.2 23.0 ± 2.5 0.2 ± 0.01 1.0 - -
V0 (OPH-11M) 29.0 ± 2.3 31.1 ± 5.3 0.9 ± 0.09 5.4 1.0 -
GV0 G0-V0 hybrid 17.0 ± 0.3 3.0 ± 0.1 5.7 ± 0.20 33.0 6.2 1.0
GV1 G0-V1 hybrid 73.0 ± 1.0 16.7 ± 2.1 4.4 ± 0.48 25.0 4.7 0.8
GV2 G9-V2 hybrid 96.3 ± 3.0 29.2 ± 0.8 3.3 ± 0.20 18.8 3.5 0.6
GV3 G9-V3 hybrid 68.6 ± 2.2 37.4 ± 2.5 2.1 ± 0.88 12.1 2.3 0.4
GV4 G10-V2 hybrid 81.9 ± 1.6 21.7 ± 5.4 3.8 ± 0.47 21.8 4.1 0.7
GV5 G10-V3 hybrid 65.3 ± 4.6 16.0 ± 5.6 4.3 ± 1.22 24.4 4.6 0.8
GV6 G11-V2 hybrid 98.0 ± 7.2 21.6 ± 3.6 4.6 ± 0.42 26.0 4.9 0.8
GV7 G11-V3 hybrid 155.5 ± 3.7 29.7 ± 0.6 5.2 ± 0.02 29.8 5.6 0.9
DFP G0 (rePON1-4E9) 176.8 ± 17.3 86.5 ± 30.1 2.1 ± 0.5 1.0 - -
V0 (OPH-11M) 556.2 ± 9.1 31.1 ± 1.9 17.9 ± 0.8 8.4 1.0 -
GV0 G0-V0 hybrid 621.5 ± 6.8 519.5 ± 31.7 1.2 ± 0.1 0.6 0.1 1.0
GV1 G0-V1 hybrid 882.4 ± 27.0 29.6 ± 4.6 30.1 ± 3.7 14.1 1.7 25.1
GV2 G9-V2 hybrid 825.2 ± 13.5 22.3 ± 4.9 37.9 ± 7.8 17.8 2.1 31.6
GV3 G9-V3 hybrid 685.6 ± 60.7 140.7 ± 42.6 5.0 ± 1.1 2.4 0.3 4.2
GV4 G10-V2 hybrid 908.6 ± 2.2 31.5 ± 3.2 29.0 ± 3.0 13.6 1.6 24.2
GV5 G10-V3 hybrid 899.4 ± 1.7 19.4 ± 5.9 48.7 ± 14.9 22.8 2.7 40.6
GV6 G11-V2 hybrid 838.3 ± 32.0 35.6 ± 9.1 24.2 ± 5.3 11.3 1.4 20.2
GV7 G11-V3 hybrid 1039.2 ± 2.8 22.3 ± 2.9 47.0 ± 6.0 22.0 2.6 39.2

Substrate Clone Mutational composition kcat(min-1) Km(μM) kcat/Km
(M-1min-1)
Fold increase to G0 Fold increase to V0 Fold increase to GV0

DSM G0 (rePON1-4E9) 0.02 ± 0.01 1054.6 ± 934.1 14.6 ± 1.9 1.0 - -
V0 (OPH-11M) 0.13 ± 0.01 1637.5 ± 252.4 77.5 ± 9.8 5.3 1.0 -
GV0 G0-V0 hybrid 0.06 ± 0.09 1210.6 ± 612.9 5.0 ± 1.1 0.3 0.1 1.0
GV1 G0-V1 hybrid 0.22 ± 0.01 748.9 ± 181.4 295.6 ± 52.9 20.3 3.8 59.1
GV2 G9-V2 hybrid 0.17 ± 0.02 832.2 ± 236.8 214.0 ± 38.4 14.7 2.8 42.8
GV3 G9-V3 hybrid 0.12 ± 0.01 680.1 ± 354.4 206.6 ± 90.1 14.2 2.7 41.3
GV4 G10-V2 hybrid 0.23 ± 0.01 708.6 ± 99.5 324.0 ± 28.9 22.2 4.2 64.8
GV5 G10-V3 hybrid 0.29 ± 0.12 10964.5 ± 5736.8 28.1 ± 5.1 1.9 0.4 5.6
GV6 G11-V2 hybrid 0.14 ± 0.02 593.8 ± 159.8 234.8 ± 37.9 16.1 3.0 46.9
GV7 G11-V3 hybrid 0.22 ± 0.01 432.5 ± 45.7 504.3 ± 48.5 34.6 6.5 100.9
Malathion G0 (rePON1-4E9) N.D. N.D. N.D. - - -
V0 (OPH-11M) 0.71 ± 0.04 2211.5 ± 160.5 319.4 ± 4.8 - 1.0 -
GV0 G0-V0 hybrid 0.21 ± 0.01 994.2 ± 33.7 212.6 ± 1.1 - 0.7 1.0
GV1 G0-V1 hybrid 1.90 ± 0.04 2736.5 ± 14.8 695.3 ± 17.5 - 2.2 3.3
GV2 G9-V2 hybrid 5.14 ± 0.29 6395.5 ± 450.4 803.8 ± 11.0 - 2.5 3.8
GV3 G9-V3 hybrid 3.75 ± 0.05 7980.0 ± 43.8 470.4 ± 3.7 - 1.5 2.2
GV4 G10-V2 hybrid 2.72 ± 0.40 7642.5 ± 139.5 356.9 ± 12.8 - 1.1 1.7
GV5 G10-V3 hybrid 12.68 ± 3.19 27460.0 ± 7891.1 464.1 ± 17.2 - 1.5 2.2
GV6 G11-V2 hybrid 1.27 ± 0.25 3274.0 ± 924.9 393.9 ± 34.6 - 1.2 1.9
GV7 G11-V3 hybrid 4.15 ± 0.02 3133.5 ± 95.4 1324.0± 47.5 - 4.2 6.2

N.D., not determined.